This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
        • Health Policy
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2022
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Conference Highlights

EAU Annual Congress 2020

EAU 2020 Prostate Cancer

  • EAU 2020: Treatment of Recurrent Lymph Node Metastatic Prostate Cancer - Radiation Is the Best Option
  • EAU 2020: Recognising Images, Tissues, Signals
  • EAU 2020: The Real Effect of Prostate Cancer Treatment: EUPROMS First-Ever Prostate Patient-Driven Quality of Life Study
  • EAU 2020: New Technology for Urology: 7T MRI Scanner
  • EAU 2020: What Are the Consequences for Implants in Urology with the New EU Directive?
View all (48 articles)

EAU 2020 Bladder Cancer

  • EAU 2020: Perioperative Therapy for Urothelial Cancer: Should We Sequence All Urothelial Cancer Patients?
  • EAU 2020: Five Things I Wish I Would Have Known Earlier in My Career: Lessons from the Mentors - Bladder Cancer
  • EAU 2020: The Future of Personalized Treatment: Test the Tumor for a Response
  • EAU 2020: Novel Urothelial Cancer Treatment Beyond PD-1/PD-L1 Inhibition
  • EAU 2020: Different Bladder Cancer Genotypes: New Treatment Options
View all (15 articles)

EAU 2020 Kidney Cancer

  • EAU 2020: Open vs. Minimally Invasive Partial Nephrectomy: What is the Evidence?
  • EAU 2020: How to Best Approach the Large Renal Mass: Tips and Tricks
  • EAU 2020: Controversies in Renal Cancer Surgery: Organ Preservation: Do the Benefits Outweigh Additional Risks? – Pro: Minimally Invasive Nephrectomy
  • EAU 2020: Controversies in Renal Cancer Surgery: Do the Benefits Outweigh Additional Risks? — Pro: Partial Nephrectomy
  • EAU 2020: Five Things I Wish I Would Have Known Earlier in My Career: Lessons from the Mentors - Kidney Cancer
View all (11 articles)

EAU 2020 Testicular and Penile Cancer

  • EAU 2020: The New Testis Cancer Biomarker miRNA 371: Ready for Prime Time?
  • EAU 2020: Robotic RPLND is Safe and Feasible
  • EAU 2020: Open RPLND is Still the Gold Standard
  • EAU 2020: Was Twitter Right? Can We Use SoMe to Better Educate Patients?
  • EAU 2020: How to Manage Testicular Microlithiasis and Carcinoma in Situ
View all (7 articles)

EAU 2020 Press Releases

  • EAU 2020: Prostate Cancer: How Can We Decide When to Treat?
  • EAU 2020: Male Sexual Worries: What has Changed in the Post-Viagra Age?
  • EAU 2020: More Porn, Worse Erectile Function
  • EAU 2020: A Largest-Ever Study by Patients Shows Prostate Cancer Treatment Has Significant Impact on Quality of Life
  • EAU 2020: Scientists Find a Switch Which May Make Prostate Cancer Spread
View all (5 articles)
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free